Adoptive cellular therapy improves Parkinson’s symptoms in mouse-model study
UF neuroscientists provide preclinical evidence for adoptive cellular therapy as a potential immunotherapy treatment to improve symptoms in genetic form of Parkinson’s.
UF neuroscientists provide preclinical evidence for adoptive cellular therapy as a potential immunotherapy treatment to improve symptoms in genetic form of Parkinson’s.
Dr. Shannon Chiu awarded five-year grant from NIA to investigate changes in LBD using diffusion-weighted MRI and task-based EEG.
In mouse-model research, HIV medication restored brain abnormalities in DYT1 dystonia.
Researchers launch study to aid in quick and accurate early Parkinson’s diagnosis versus two related but distinct disorders.
The program trains doctoral students to become independent researchers in Parkinson’s disease, dystonia, tremor and ataxia.
Dr. David Vaillancourt leads international study demonstrating that a non-invasive, automated MRI method can pinpoint various types of Parkinson’s disease and Parkinson’s-like syndromes.
National Institute of Neurological Disorders and Stroke leadership recently visited with Predoctoral Interdisciplinary Training in Movement Disorders and Neurorestoration program participants.
In the laboratory of David Vaillancourt, Ph.D., researchers are applying a groundbreaking, noninvasive imaging biomarker they identified to discover better diagnostics and treatment of Parkinson's disease.
A review by Dr. David Vaillancourt, a member of the MBI's executive committee, was recently featured on the cover of the journal Movement Disorders.